Table 2.
Variable | All subjects | Control | Schizophrenia | ||||
---|---|---|---|---|---|---|---|
GluN2B | GluN2B | GluN2B | GluN2B | GluN2B | GluN2B | ||
Protein | Binding | Protein | Binding | Protein | Binding | ||
n | 38 | 41 | 19 | 21 | 19 | 20 | |
Age at death | r | 0.16 | ‐0.309 | 0.207 | -0.408 | 0.152 | -0.212 |
p | 0.338 | 0.049 | 0.395 | 0.067 | 0.534 | 0.369 | |
Post-mortem interval | r | ‐0.318 | 0.054 | ‐0.483 | 0.061 | -0.116 | 0.030 |
p | 0.051 | 0.738 | 0.036 | 0.794 | 0.636 | 0.901 | |
pH | r | ‐0.386 | 0.068 | ‐0.662 | 0.226 | 0.162 | -0.255 |
p | 0.017 | 0.671 | 0.002 | 0.324 | 0.506 | 0.278 | |
Brain weight | r | 0.067 | -0.029 | 0.028 | 0.152 | 0.023 | -0.218 |
p | 0.688 | 0.855 | 0.908 | 0.512 | 0.926 | 0.356 | |
Duration of illness | r | N/A | N/A | N/A | N/A | -0.056 | -0.192 |
p | N/A | N/A | N/A | N/A | 0.819 | 0.430 | |
Age of onset | r | N/A | N/A | N/A | N/A | 0.313 | 0.007 |
p | N/A | N/A | N/A | N/A | 0.193 | 0.977 | |
Estimated daily antipsychotic drug dose | r | N/A | N/A | N/A | N/A | -0.156 | -0.368 |
p | N/A | N/A | N/A | N/A | 0.525 | 0.111 |
Significant and borderline significant correlations are highlighted in bold. N/A, not applicable.